Eli Lilly Acquires Adverum Biotechnologies to Advance Gene Therapy for Vision Restoration
Eli Lilly and Company has announced a definitive agreement to acquire Adverum Biotechnologies, Inc., a clinical-stage biotechnology firm specializing in…
Eli Lilly and Company has announced a definitive agreement to acquire Adverum Biotechnologies, Inc., a clinical-stage biotechnology firm specializing in…
After losing his vision as a teenager and enduring more than 50 failed surgeries, a Canadian man has regained sight…